The Liver Meeting Debrief 2: Basic Science, Hepatitis, Hepatocellular Carcinoma, Cholestatic Liver Disease, Metabolic Dysfunction–Associated Steatotic Liver Disease, Alcohol-Associated Liver Disease, and MetALD

Nov 09 2026
Convention Center: General Session, Hall A
8:00 AM - 10:30 AM
Captured/recorded session Recorded
CE Credits CE Credits

Description

The debrief sessions summarize the highest impact papers addressing key topics across the field of hepatology presented during The Liver Meeting. A group of original research reports reflecting major advances in hepatology are succinctly reviewed. Debrief 2 addresses basic science research, hepatitis, hepatocellular carcinoma, cholestatic liver disease, metabolic dysfunction–associated liver disease, alcohol-associated liver disease, and MetALD.

Presentations

8:00 AM - 8:25 AM
Convention Center - General Session, Hall A
Recorded session

Basic Science Debrief

Yasuko Iwakiri, PhD, FAASLD | Presenter
8:50 AM - 9:15 AM
Convention Center - General Session, Hall A
Recorded session

Cholestatic Liver Disease Debrief

Craig S Lammert, MD, MS, | Presenter
9:15 AM - 9:40 AM
Convention Center - General Session, Hall A
Recorded session

Hepatocellular Carcinoma Debrief

Patricia Jones | Presenter
9:40 AM - 10:05 AM
Convention Center - General Session, Hall A
Recorded session

Alcohol-Associated Liver Disease and MetALD Debrief

Gene Y. Im, MD, , FAASLD | Presenter
10:05 AM - 10:30 AM
Convention Center - General Session, Hall A
Recorded session

Metabolic Dysfunction–Associated Steatotic Liver Disease Debrief

Vincent Chen | Presenter
8:25 AM - 8:50 AM
Convention Center - General Session, Hall A
Recorded session

Hepatitis Debrief

Robert Gish, MD, FAASLD | Presenter

Objectives

  • Describe recent findings and/or advances in hepatology regarding basic science research, hepatitis, hepatocellular carcinoma, cholestatic liver disease, and steatotic liver disease.